BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1918169)

  • 1. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
    Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
    J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
    Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
    Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer.
    Rodriguez-Cimadevilla JC; Beauchemin V; Villeneuve L; Letendre F; Shaw A; Hoang T
    Blood; 1990 Oct; 76(8):1481-9. PubMed ID: 2207323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor alpha in blast cells of acute myeloblastic leukemia.
    Murohashi I; Tohda S; Imai Y; Hirai Y; Nara N
    Exp Hematol; 1993 Jul; 21(7):846-51. PubMed ID: 8319777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia.
    Murohashi I; Tohda S; Suzuki T; Nagata K; Yamashita Y; Nara N
    Exp Hematol; 1990 Feb; 18(2):133-7. PubMed ID: 2406155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
    Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF.
    Bradbury D; Bowen G; Kozlowski R; Reilly I; Russell N
    Leukemia; 1990 Jan; 4(1):44-7. PubMed ID: 2404162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Product of the Steel locus can replace leukemic cell interaction.
    Cáceres-Cortés JR; Hoang T
    Cancer Res; 1992 Oct; 52(19):5208-12. PubMed ID: 1382839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
    Oster W; Cicco NA; Klein H; Hirano T; Kishimoto T; Lindemann A; Mertelsmann RH; Herrmann F
    J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
    Rogers SY; Bradbury D; Kozlowski R; Russell NH
    Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors.
    Herrmann F; Oster W; Mertelsmann R
    Klin Padiatr; 1990; 202(4):212-7. PubMed ID: 2203937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin 1 beta receptors on blast cells in acute myeloblastic leukemia: comparison with interleukin 1 beta proliferative activity.
    Murohashi I; Tohda S; Suzuki T; Nagata K; Yamashita Y; Nara N; Aoki N
    Cancer Res; 1989 Jun; 49(12):3431-5. PubMed ID: 2524253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
    Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
    Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of various hematopoietic growth factors on acute myeloblastic leukemia blasts].
    Almeida J; del Cañizo MC; Vidriales B; Hernández MD; Galende J; San Miguel J
    Sangre (Barc); 1996 Feb; 41(1):3-8. PubMed ID: 8779032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells.
    Tuyt LM; Dokter WH; Esselink MT; Vellenga E
    Eur Cytokine Netw; 1995; 6(4):231-5. PubMed ID: 8789288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony stimulating factor and interleukin-3 regulate the production of an interleukin-1 inhibitor by the differentiated AML-193 leukemic cell line.
    Kindler V; Shields J; Ayer D; Benotto W; Mazzei GJ
    Eur Cytokine Netw; 1990; 1(3):169-76. PubMed ID: 2151793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.